Toronto
Americas
Our Toronto office is conveniently located in the heart of the city’s financial and legal district, close to the courts and the offices of many large business enterprises and innovation centres. We offer comprehensive IP-related services covering a variety of sectors along with a broad range of industries and technologies.
Toronto is distinguished as the fourth largest city in North America as well as the financial and business capital of Canada. Toronto is also recognized for its diversified strengths in technology, financial services, life sciences, clean-tech and renewable energy innovation, as well as food services, and is home to just over 2 million businesses exporting just over $70 billion in goods and services annually.
Our highly recognized and experienced team of lawyers, patent and trademark agents, have in-depth experience in all IP-related services including the protection, management and enforcement of patents, trademarks and copyrights, trade secrets and confidential information, as well as IP counselling, transactions and litigation. Our team can also assist in related areas of domain name acquisitions and disputes, privacy, data protection, as well as marketing and advertising law.
Show MoreWe have a robust domestic and international client base in Toronto which includes multinational corporations, small Canadian and international corporations, universities and other research institutions and individuals. Our team’s extensive knowledge spans numerous technical disciplines including, electronics, computer, artificial intelligence, chemistry, pharmaceuticals, and biotechnology, as well as the creative, entertainment, fashion and consumer goods industries, with related expertise in privacy, data protection, marketing and regulatory law including packaging and labelling.
Marks & Clerk
33 Yonge Street
Suite 300
Toronto, Ontario
M5E 1G4
Canada
Our Toronto team
Key contact
Latest Insights
Late-stage functionalisation: a unique perspective from a research scientist turned patent attorney
Late-stage functionalisation has emerged as a valuable enabling tool within the arsenal of a medicinal chemist. As newer synthetic methods become developed for the generation of small molecules, so too has the chemical space that medicinal chemists will have access to. Of course, these methods are valuable to the R&D team – but did you know that late-stage functionalisation will also likely have an impact on the IP profession?
Read more
UK trade marks - 2023 in review
Each year the UKIPO publish facts and figures relating to the trade mark, patent and design filings of the previous calendar year. We have provided previous reports for TM activity 2021 and 2022. The UKIPO recently shared the figures for 2023 with us, and there are some intriguing patterns emerging - especially as regards examination of new TM applications.
Read more
Advances in processing sequential data using spiking neural networks (SNNs)
Spiking Neural Networks (SNNs) represent the third generation of neural networks, offering a more brain-like approach to processing information. By utilising spiking neurons, SNNs promise energy efficiency and enhanced capabilities in time-dependent tasks, though challenges remain in training and applying them to conventional tasks.
Read more